Dedicated to the philosophy
"You can learn to control this disease
instead of letting it control you!"
Monday, Aug 18,
2014 Volume #13 -- Issue #33
Susie Bowers, Editor ---
Copyright © 2014 COPD-International.com
All rights reserved.
FREE BY SUBSCRIPTION ONLY! Subscription information is at
the end of this
newsletter. THIS IS AN AUTOMATED MESSAGE
PLEASE DO NOT REPLY. This newsletter
is published on Mondays.
> > > > > > >
IN THIS ISSUE < < < < < < <
==> Follow Us
==> COPD News
==> New Hope/Innovations
==> Featured Articles - Fall Allergies
==> COPD Word of the Week
==> Closing Thought
==> Subscribe/Unsubscribe Information
> > > > > > > > WELCOME < < < < < < < <
We are a group of fellow COPD sufferers, caregivers and others
interested in this disease. Our online community is devoted to
helping one another to live the best life possible with this
debilitating illness through interactive support.
As many of us have found, COPD is a disease of many faces,
contradictions and components. Therefore, our diversified community
is here to share its combined wealth of knowledge and information, so
we may all become well-informed patients and take control of our
disease rather than letting this disease control us.
We welcome your input and participation in our newsletters and will
review for publication any pertinent information you wish to share
with others on COPD and related topics. Also, periodically we will
feature stories and information from guest writers. If you wish to
contribute to the newsletter, please contact us at
Yours in Health,
Susie in Delaware
Editor's Note: There are several exceptionally long links
in this edition. Please cut and paste the entire address
into your browser if you have trouble opening the page.
> > > > > > > > FOLLOW US < < < < < < < <
FOLLOW US ON FACEBOOK
FOLLOW US ON TWITTER
FOLLOW OUR BLOG
VISIT OUR MOBILE WEBSITE
No app to download - simply enter COPD-International.com on your
mobile device. Full URL:
> > > > > > > > COPD NEWS < < < < < < < <
NEW INHALED COPD DRUG WINS FDA APPROVAL
The U.S. Food and Drug Administration (FDA) has approved the
once-daily bronchodilator inhalation spray olodaterol (Striverdi
Respimat) for the long-term treatment of airflow obstruction in
patients with chronic obstructive pulmonary disease, including
chronic bronchitis and/or emphysema.
The announcement follows a recommendation in February 2013 from the
Pulmonary-Allergy Drugs Advisory Committee (PADAC), of the FDA, that
the clinical data submitted with the new drug application provided
substantial and convincing evidence to support the approval of
Boehringer Ingelheim's new drug.
Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II
in the FDA's Center for Drug Evaluation and Research, says in the
press announcement that:
"The availability of this new long-term maintenance medication
provides an additional treatment option for the millions of Americans
who suffer with COPD."
COPD is a serious lung disease and the third leading cause of death
among Americans. People with COPD have difficulty breathing,
experience wheezing, chest tightness, cough and shortness of breath.
The condition gets worse over time and treatment is made more
difficult because COPD is often accompanied by other serious medical
conditions, such as heart disease, diabetes, osteoporosis and
The drug carries a boxed warning that this class of drug is known to
increase the risk of asthma-related deaths. The patient medication
guide approved with the drug has instructions on how to use it and
describes the risks of taking it. See Article:
EDITOR'S NOTE: Although not an expert, I have always been
told not to keep medications in the bathroom.
SET RITUALS MAY HELP PEOPLE TO TAKE THEIR MEDS
Storing it in the bathroom and making it part of a daily routine may
be helpful advice that doctors can give their older asthmatic
patients who struggle to remember to take their daily prescribed
medication. This advice comes from Alex Federman, associate professor
of Medicine at the Icahn School of Medicine in New York City, senior
author of a study which discusses how elderly asthmatics cope with
taking their inhaled corticosteroid medication as prescribed. The
findings appear in the Journal of General Internal Medicine,
published by Springer.
The regular use of such medication helps to control the chronic lung
inflammation characteristic of asthma, a disease that affects up to 9
percent of Americans older than 65 years. However, the fact that
elderly patients often struggle to stick to their prescriptions is
worrying, as approximately two in every three asthma-related deaths
in the U.S. occur among people older than 55 years old. See Article:
Make browsing in our Library part of your daily surfing routine at
REVIEW OF THE PULMONARY HORIZONS CONFERENCE
Pulmonary Horizons 1st Annual Conference was held in San Diego, CA
on August 16 - 17, 2014. With the focus of the conference on
"quality care for the patient", they covered many of the major
concerns of patients and caregivers.
> > > > > > > > NEW HOPE/INNOVATIONS < < < < < < < <
STUDY: INVENTION MONITORS VITAL SIGNS
A disposal, plastic listening device that attaches to the abdomen may
help doctors definitively determine which post-operative patients
should be fed and which should not, an invention that may improve
outcomes, decrease healthcare costs and shorten hospital stays,
according to a UCLA study.
Some patients who undergo surgery develop a condition called
post-operative ileus (POI), a malfunction of the intestines. The
condition causes patients to become ill if they eat too soon, which
can lengthen an affected patient's hospital stay by two to three
days. Until now, there was no way to monitor for POI other than
listening to the belly for short periods with a stethoscope, said
study first author Dr. Brennan Spiegel, a professor of medicine at
the David Geffen School of Medicine at UCLA and the UCLA Fielding
School of Public Health. See More:
REVIEW FINDS ASPIRIN CUTS CANCER RATES
Taking a small daily dose of aspirin can significantly reduce the
risk of developing - or dying from - bowel, stomach and oesophageal
cancer, according to a large review of scientific studies.
Researchers who analyzed all available evidence from studies and
clinical trials assessing benefits and harm found that taking aspirin
for 10 years could cut bowel cancer cases by around 35 percent and
deaths from the disease by 40 percent.
Rates of oesophageal and stomach cancer were cut by 30 percent and
deaths from these cancers by 35 to 50 percent. See More:
> > > > > > > > ALERTS/RECALLS/WARNINGS < < < < < < < <
U.S. DEPARTMENT OF AGRICULTURE RECALLS
The link below leads to the list of active recall cases of the United
States Department of Agriculture's (USDA) Food Safety and Inspection
Service (FSIS). See current recalls at
U.S. FDA RECALLS
To view current U.S. Food and Drug Administration
> > > > > > > > FEATURED ARTICLE < < < < < < < <
It's almost fall, and the blooms of summer have faded. So how come
you're still sneezing? Fall allergy triggers are different, but
they can cause just as many symptoms as you have in spring and
What Causes Fall Allergies?
Ragweed is the biggest allergy trigger in the fall. Though the
yellow-flowering weed usually starts releasing pollen in August, it
can last into September and October. About three-quarters of people
who are allergic to spring plants are also allergic to ragweed.
Ragweed pollen loves to get around. Even if it doesn't grow where you
live, it can still travel for hundreds of miles on the wind. For some
people who are allergic to ragweed, foods like bananas, melon,
zucchini and certain other fruits and vegetables can also cause
symptoms. See More:
FIGHTING ALLERGIES FROM THE INSIDE
The AAAAI offers tips to indoor allergy sufferers With the decrease
in temperature and arrival of winter weather, you may be more than
happy to stay indoors. However, for people who suffer from indoor
allergies, staying indoors may make them just as miserable as the
Allergies affect between 40 and 50 million people in the United
States, according to the American Academy of Allergy, Asthma and
Immunology (AAAAI). While seasonal allergies may come and go,
perennial, or year-round, allergy sufferers deal with stuffy or runny
noses, itchy eyes, sneezing, and wheezing 365 days a year.
Indoor allergies are the body's physical reactions to inhaled
airborne particles called allergens. These indoor allergens usually
include house dust mite droppings, animal dander, cockroach droppings
and indoor mold. See Tips:
> > > > > > > > NUTRITION/WELLNESS < < < < < < < <
"GLUTEN-FREE" NOW MEANS WHAT IT SAYS
In August 2013, the Food and Drug Administration (FDA) issued a final
rule that defined what characteristics a food has to have to bear a
label that proclaims it "gluten-free." The rule also holds foods
labeled "without gluten," "free of gluten," and "no gluten" to the
Manufacturers had one year to bring their labels into compliance. As
of August 5, 2014, any food product bearing a gluten-free claim
labeled on or after this date must meet the rule's requirements.
> > > > > > > > COMMUNITY UPDATE < < < < < < < <
WELCOME NEW SUBSCRIBERS!
We welcome all our new subscribers and invite you to join our g
e-mail li sts and check out our chat rooms, where you can talk freely
about COPD in an atmosphere of fellowship. The link to the chat
schedules can be found on our Home Page or just drop in anytime you
have a need to talk.
KEEPING IN TOUCH (KIT) WITH OUR COPD FRIENDS
Over the years, we have had many of our active COPD friends simply
disappear suddenly. As COPD patients, we would begin to worry about
them, not knowing if they were ill, in the hospital, or worse. Others
who live alone have found themselves in the unfortunate situation of
winding up in the hospital due to an emergency, with no means to
contact their friends and support lists. For many, COPD also tends to
make hermits of them, with diminishing contact with others. All three
of these situations have been addressed in the new "Keep In Touch"
program at COPD International. For more information, or to join, go
DEDICATION TO THOSE WHO HAVE GONE BEFORE US
Some we have known by name, others only by nickname and still
others have remained totally unknown, preferring to read, learn and
seek comfort in the knowledge that they were not alone.
In honor all COPD patients everywhere, both known and
who have gone on before us, we have dedicated a section
website. See Tributes:
MESSAGE BOARD ON SURGICAL OPTIONS FOR COPD
Thanks to the generous contribution of time and experience by some of
our regulars here at COPD International, we were able to open a new
message board for the exchange of information and support on surgical
options for COPD. This new board will cover subjects such as LVRS,
transplants and valve procedures, etc. For a complete listing of all
our message boards (forums), please go to
COPD NEWS/INFORMATION FEATURE
"COPD Info" brings you the latest news, articles and
information from a wide variety of resources on a very timely basis.
For those of you with news readers, there is also an RSS
To express your loving thoughts, get-well wishes and prayers for
our fellow community members, who are very ill or hospitalized,
please go to
HOSTED DAILY CHAT SCHEDULE
We currently have a total of 4 Hosted "open" Chats. These chats are
an opportunity for you to visit with others in a relaxed setting.
Non-COPD related experiences are often shared along with information
and support on COPD subjects. Note: COPD questions and questions
from newcomers take priority in ALL our chats.
These daily scheduled chats are held in the Main Chat Room at:
10:30 a.m., 3 p.m., 9 p.m. and Midnight (Eastern [EDT] GMT -4hrs)
The full chat schedule is at:
> > > > > > > > LINK DIRECTORY < < < < < < < <
-- General Information on Clinical Trials
-- Continually Updated List of COPD Clinical Trials
-- Quit Smoking Support
-- Exercise Forum
-- Caregivers Support
-- COPD Advocate Bill Horden Library
-- COPD Library
-- Welcome Wagon
-- To Volunteer
-- Oxygen Therapy and Equipment (including POC
Don't forget to checkout all our support programs listed on our
Home Page at
> > > > > > > > JUST FOR FUN < < < < < < < <
> > > > > > > > RECIPE < < < < < < < <
Editor's Note: Recipes are not diabetes-friendly
unless otherwise noted.
BUFFALO CHICKEN MAC AND CHEESE
Penne pasta, canned chicken in Buffalo sauce, Cheddar
cheese sauce, celery and blue cheese combine for a sassy
mac & cheese that's simply irresistible! This recipe is so
easy and delicious you'll want to make it again and again!
Prep: 20 minutes
Cook: 5 minutes
Makes: 4 servings (about 1¼ cups each)
What You'll Need
1/3 of a 1-pound package penne pasta, cooked and drained
(about 3 cups cooked)
1 jar (14.5 ounces) Prego Creamy Cheddar Cheese Sauce
1 can (9.75 ounces) Swanson White Premium Chunk Chicken
Breast in Buffalo Style Sauce, undrained
1 stalk celery, thinly sliced (about 1/2 cup)
1/2 cup crumbled blue cheese or shredded Monterey Jack
How to Make It
Heat the penne, cheese sauce, chicken with sauce, celery
cheese in a 3-quart saucepan over medium heat for 5
until hot and bubbling, stirring often.
> > > > > > > > COPD WORD OF THE WEEK < < < < < < < <
Bluish color of the skin due to insufficient oxygen in
> > > > > > > > CLOSING THOUGHT < < < < < < < <
"You will do foolish things, but do
them with enthusiasm."
- Colette -
For Your Readership
Newsletters are archived in the COPD-International online Library.
links to outside sources cannot be guaranteed after
"COPD-International Newsletter" is an opt-in ezine available by
subscription only. You must have sent an e-mail request or visited
site to request this subscription. We neither use nor
endorse the use of
"spam." This newsletter is never sent to anyone
who has not requested it and
we NEVER share your e-mail address with
© 2013 COPD-International.com, except where otherwise indicated. All
rights reserved worldwide. Reprint only with permission from
holder(s). All trademarks are property of their respective
content provided "as is" without warranty of any kind.
All Disclaimers Apply: The information and guidance provided in this
newsletter should never be interpreted as a diagnosis, treatment
plan or any
other form of professional service.
All information provided should be judged as individual "opinions"
discussed with a qualified health care professional before any
treatment or therapy is started.
Links in this newsletter to other Internet sites are not
any products or services associated with such sites.